QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, July 6, 2005, 25(27):6271-6277; doi:10.1523/JNEUROSCI.1306-05.2005

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (12) Citing Articles via Google Scholar Google Scholar Articles by Miao, J. Articles by Van Nostrand, W. E. Search for Related Content PubMed PubMed Citation Articles by Miao, J. Articles by Van Nostrand, W. E.

 Previous Article  |  Next Article 

Neurobiology of Disease
Reducing Cerebral Microvascular Amyloid- Protein Deposition Diminishes Regional Neuroinflammation in Vasculotropic Mutant Amyloid Precursor Protein Transgenic Mice

Jianting Miao,¹ Michael P. Vitek,² Feng Xu,¹ Mary Lou Previti,¹ Judianne Davis,¹ and William E. Van Nostrand¹

¹Department of Medicine, Stony Brook University, Stony Brook, New York 11794-8153, and ²Department of Neurology, Duke University Medical Center, Durham, North Carolina 27710

Cerebral microvascular amyloid- (A) protein deposition is emerging as an important contributory factor to neuroinflammation and dementia in Alzheimer's disease and related familial cerebral amyloid angiopathy disorders. In particular, cerebral microvascular amyloid deposition, but not parenchymal amyloid, is more often correlated with dementia. Recently, we generated transgenic mice (Tg-SwDI) expressing the vasculotropic Dutch (E693Q)/Iowa (D694N) mutant human A precursor protein in brain that accumulate abundant cerebral microvascular fibrillar amyloid deposits. In the present study, our aim was to assess how the presence or absence of fibrillar A deposition in the cerebral microvasculature affects neuroinflammation in Tg-SwDI mice. Using Tg-SwDI mice bred onto an apolipoprotein E gene knock-out background, we found a strong reduction of fibrillar cerebral microvascular A deposition, which was accompanied by a sharp decrease in microvascular-associated neuroinflammatory cells and interleukin-1 levels. Quantitative immunochemical measurements showed that this reduction of the neuroinflammation occurred in the absence of lowering the levels of total A40/A42 or soluble A oligomers in brain. These findings suggest that specifically reducing cerebral microvascular fibrillar A deposition, in the absence of lowering either the total amount of A or soluble A oligomers in brain, may be sufficient to ameliorate microvascular amyloid-associated neuroinflammation.

Key words: amyloid- protein; transgenic mice; cerebral microvasculature; neuroinflammation; Alzheimer's disease; vasculotropic mutant

---

Received Jan 11, 2005; revised May 24, 2005; accepted May 24, 2005.

This article has been cited by other articles:

				G. D. Van Vickle, C. L. Esh, I. D. Daugs, T. A. Kokjohn, W. M. Kalback, R. L. Patton, D. C. Luehrs, D. G. Walker, L.-F. Lue, T. G. Beach, et al. Tg-SwDI Transgenic Mice Exhibit Novel Alterations in A{beta}PP Processing, A{beta} Degradation, and Resilient Amyloid Angiopathy Am. J. Pathol., August 1, 2008; 173(2): 483 - 493. [Abstract] [Full Text] [PDF]

				F. Xu, M. P. Vitek, C. A. Colton, M. L. Previti, N. Gharkholonarehe, J. Davis, and W. E. Van Nostrand Human Apolipoprotein E Redistributes Fibrillar Amyloid Deposition in Tg-SwDI Mice J. Neurosci., May 14, 2008; 28(20): 5312 - 5320. [Abstract] [Full Text] [PDF]

				R. Fan, F. Xu, M. L. Previti, J. Davis, A. M. Grande, J. K. Robinson, and W. E. Van Nostrand Minocycline Reduces Microglial Activation and Improves Behavioral Deficits in a Transgenic Model of Cerebral Microvascular Amyloid J. Neurosci., March 21, 2007; 27(12): 3057 - 3063. [Abstract] [Full Text] [PDF]

				C. A. Colton, M. P. Vitek, D. A. Wink, Q. Xu, V. Cantillana, M. L. Previti, W. E. Van Nostrand, J. B. Weinberg, and H. Dawson NO synthase 2 (NOS2) deletion promotes multiple pathologies in a mouse model of Alzheimer's disease PNAS, August 22, 2006; 103(34): 12867 - 12872. [Abstract] [Full Text] [PDF]

				T. Van Dooren, D. Muyllaert, P. Borghgraef, A. Cresens, H. Devijver, I. Van der Auwera, S. Wera, I. Dewachter, and F. Van Leuven Neuronal or Glial Expression of Human Apolipoprotein E4 Affects Parenchymal and Vascular Amyloid Pathology Differentially in Different Brain Regions of Double- and Triple-Transgenic Mice Am. J. Pathol., January 1, 2006; 168(1): 245 - 260. [Abstract] [Full Text] [PDF]

				R. Koldamova, M. Staufenbiel, and I. Lefterov Lack of ABCA1 Considerably Decreases Brain ApoE Level and Increases Amyloid Deposition in APP23 Mice J. Biol. Chem., December 30, 2005; 280(52): 43224 - 43235. [Abstract] [Full Text] [PDF]

				V. Hirsch-Reinshagen, L. F. Maia, B. L. Burgess, J.-F. Blain, K. E. Naus, S. A. McIsaac, P. F. Parkinson, J. Y. Chan, G. H. Tansley, M. R. Hayden, et al. The Absence of ABCA1 Decreases Soluble ApoE Levels but Does Not Diminish Amyloid Deposition in Two Murine Models of Alzheimer Disease J. Biol. Chem., December 30, 2005; 280(52): 43243 - 43256. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help